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Abstract: Stress has been extensively studied as a psychosomatic factor associated with breast 
cancer. This study aims to review the prevalence of post-traumatic stress disorder (PTSD), its 
associated risk factors, the role of predicting factors for its early diagnosis/prevention, the impli-
cations for co-treatment, and the potential links by which stress could impact cancer risk, by 
closely examining the literature on breast cancer survivors. The authors systematically reviewed 
studies published from 2002 to 2016 pertaining to PTSD, breast cancer and PTSD, and breast 
cancer and stress. The prevalence of PTSD varies between 0% and 32.3% mainly as regards the 
disease phase, the stage of disease, and the instruments adopted to detect prevalence. Higher 
percentages were observed when the Clinician Administered PTSD Scale was administered. In 
regard to PTSD-associated risk factors, no consensus has been reached to date; younger age, 
geographic provenance with higher prevalence in the Middle East, and the presence of previous 
cancer diagnosis in the family or relational background emerged as the only variables that were 
unanimously found to be associated with higher PTSD prevalence. Type C personality can be 
considered a risk factor, together with low social support. In light of the impact of PTSD on 
cognitive, social, work-related, and physical functioning, co-treatment of cancer and PTSD is 
warranted and a multidisciplinary perspective including specific training for health care pro-
fessionals in communication and relational issues with PTSD patients is mandatory. However, 
even though a significant correlation was found between stressful life events and breast cancer 
incidence, an unequivocal implication of distress in breast cancer is hard to demonstrate. For 
the future, overcoming the methodological heterogeneity represents one main focus. Efficacy 
studies could help when evaluating the effect of co-treating breast cancer and post-traumatic 
stress symptoms, even if all the criteria for a Diagnostic and Statistical Manual of Mental Dis-
orders diagnosis are not fulfilled.
Keywords: PTSD, post-traumatic stress disorder, breast cancer, disease management
Background
When women affected by breast cancer are asked to recall the very moment of their 
diagnosis and cancer experience, a series of symptoms may appear including hyper-
arousal, emotional numbness, the sensation of the situation happening to a person other 
than self, and intrusive thinking together with nightmares and flashbacks that guide the 
clinician to understand how traumatic the cancer diagnosis was across the life span.
The Diagnostic and Statistical Manual of Mental Disorders (DSM) version IV 
recognized that it is possible for a person to receive a diagnosis of post-traumatic 
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stress disorder (PTSD) as a consequence of life-threatening 
disease.1 In the newer DSM-V, a medical disease such as 
cancer is considered a traumatic event only when it is sudden 
and “catastrophic”.2
The prevalence of PTSD diagnosis in breast cancer is 
higher than that in colorectal, head and neck, and prostate 
cancers but lower than that in brain, gynecological, and 
hematological cancers.3
It is important that such a psychological disorder is 
detected in order to implement appropriate short- and 
long-term health care policies and to sustain adherence 
and compliance in patients whose psychological symptoms 
cause defects in information processing, problem-solving 
abilities, decision-making processes, and in communication, 
relational, and social issues.3,4
The prevalence of PTSD symptoms varies hugely on the 
basis of diagnostic criteria considered, psychological instru-
ments applied in research studies, disease phase, and stage 
in which the prevalence study is conducted.4,5
This paper aims to investigate the literature regarding 
the prevalence of PTSD in breast cancer patients consider-
ing the associated sociodemographic and comorbidity risk 
factors. In addition, it summarizes the potential links and 
proposed mechanisms by which stress impacts cancer risk, 
the implication for co-treatment of cancer and related PTS 
symptomatology, and the role played by predictive factors 
for early diagnosis and prevention.
Methods
Search strategy to identify review articles 
for this analysis
To identify the relevant review literature, we chose a 14-year 
period (December 2002–December 2016). The main reason 
for this period is that one of the most frequently cited review 
papers on PTSD in breast cancer patients6 first appeared at 
the beginning of the 21st century.
We used the OVID bibliographic software to search three 
computerized databases: OVID MEDLINE(R), PsycINFO, 
and SCOPUS. OVID allows multiple searches and deletion 
of duplicates. Various combinations of database-specific 
controlled vocabulary (subject headings) were used, supple-
mented by keywords, title, and abstract terms for the concepts 
and synonyms relating to PTSD and breast cancer. Keywords 
used were cancer AND PTSD, cancer AND post-traumatic 
stress disorder, breast cancer AND stress, breast cancer AND 
PTSD. The search was limited to the English language and 
resulted in 520 papers (Figure 1). From these, we extracted 
23 relevant papers as described in Table 1.
SR, PA, and a trained graduate student (CC) reviewed the 
titles and abstracts from the OVID search to extract relevant 
papers. When we failed to reach consensus, GP was consulted 
to review the titles and abstracts of papers. We extracted 
only those papers with a major focus on factors implicated 
in PTSD in breast cancer patients, the associated sociode-
mographic and comorbidity risk factors, and potential links 
and proposed mechanisms by which stress impacts cancer 
risk in adult breast cancer patient populations.
We excluded papers in which 1) the focus was not stress 
related, 2) the primary outcomes were not addressed in the 
breast population, and 3) only pediatric populations were 
included. We also excluded papers focused on small qualita-
tive studies, theoretical contributions, and other professional 
practice guidelines. However, we included other high-quality 
systematic reviews published after 2002.
Quality of psycho-oncology papers
One goal of our review was to characterize the overall quality 
of the papers dealing with PTSD in breast cancer patients. 
We did this by describing the quality of papers by 1) using a 
systematic and comprehensive search strategy and by 2) con-
trolling for the effects of lesser quality studies on results. We 
referred to the Cochrane Handbook for Systematic Reviews 
of Interventions.7
A subjective assessment of methodological quality for 
randomized controlled trials (RCTs) and observational stud-
ies included was conducted by three authors (PA, SR, and 
CC) on the following items, in which each component was 
categorized as low, moderate, or high: likelihood of selection 
Figure 1 Flowchart of literature search.
520 studies 
483 studies
excluded
37 studies
potentially relevant
14 studies excluded
as did not meet
inclusion criteria
23 studies included
in the review
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bias, study design, control of important confounders, blind-
ing, data collection methods, withdrawals and dropouts, and 
overall rating. The overall rating is described in Table 1. We 
excluded studies evaluated as “low.”
Search strategy
Our first analysis examines whether the search strategy used 
to identify relevant studies could be considered systematic 
and comprehensive. A systematic search strategy is one that 
includes a methodology that allows readers to gain a com-
prehensive understanding of the study. A systematic review 
should, at the very least, specify the study design, setting, 
enrollment criteria, and primary and secondary objectives 
and related end points.
Based on these considerations, we decide to select 
randomized studies, as well as cohort studies with a good 
study design quality and review/meta-synthesis that included 
relevant controlled studies.
Quality controls
Our second analysis examines how studies were selected 
for inclusion in the review. We selected only those papers 
checked that met certain methodological quality criteria.
We sorted papers into three categories: 1) those that 
included both RCTs and nonrandomized intervention studies, 
2) those that included only RCTs, and 3) those that included 
systematic reviews.
For that which regards the risk factors associated with 
PTSD that emerged from the literature systematic review, we 
grouped them into three broad categories: clinical oncology 
variables such as tumor characteristics, disease stage, and 
type of surgery; psychological variables such as previous 
lifetime traumas or concomitant psychological/psychiatric 
symptoms; and sociodemographic variables such as age at 
evaluation, level of education, socioeconomic status, and 
race/ethnicity.
Results
PTSD and post-traumatic stress 
symptoms in breast cancer patients: 
whether cancer can function as a 
traumatic stressor
In a meta-analysis by Swartzman et al,3 the summary propor-
tion (%) of patients showing PTSD after breast cancer diag-
nosis considering 38 studies was around 10% (8%–12.5%). 
The prevalence of PTSD appeared high if compared to other 
mental disorders in cancer setting.
Studies included in our review varied greatly mainly as 
regard to the disease phase in which prevalence was studied, 
to the stage of disease and to instruments adopted to detect 
prevalence as described in Table 2: for instance, Hegel et al8 
studied the prevalence of PTSD in 236 newly diagnosed breast 
stage I–II or III cancer patients at the time of their presurgi-
cal consultation and found a prevalence of 10% of PTSD. In 
the study by Mehnert and Koch,9 studying 127 breast cancer 
patients postsurgery, it was found that only 2.4% patients 
met the criteria for a mild-to-moderate cancer-related PTSD.
Similarly, Shelby et al10 studied a sample of 74 breast 
cancer patients with node-positive disease (stages II and 
III), treated with breast-conserving surgery at diagnosis/
treatment and 18 months later. Diagnostic PTSD rates were 
demonstrated to be low (3%–14%) but PTSD subsyndromal 
symptomatology, falling short of the diagnostic criteria of 
the DSM-IV, may occur in upward of 50% of patients. A 
higher percentage was found in the study by Vin-Raviv 
et al,11 where the 23% of 1139 women with newly diagnosed 
localized breast cancer experienced PTSD symptoms. These 
symptoms decreased over time, 16.5% had PTSD symptoms 
at 4-month follow-up; 12.6% at the second follow-up. Also, 
other studies confirmed these results.4,5,10,12
In a follow-up study by Elklit and Blum,13 the prevalence 
of PTSD symptoms 1 year after early breast cancer diagnosis 
was ~13% of the patients, while the large Danish study by 
O’Connor et al12 showed that in a sample of 3343 Danish 
women after surgery, the prevalence of PTSD symptoms was 
20.1% at 3 months and 14.3% at 15 months.
Alkhyatt et al14 at the Nuclear Medicine Hospital in 
Iraq found relatively low rates of cancer-related PTSD: 5% 
at any time post–cancer diagnosis (up to 20 months) with 
liberal criteria and only 3% with more stringent criteria in 
a sample of 100 women aged 25–75 years with early-stage 
breast cancer and being 4–12 months post–cancer treatment.
Arnaboldi et al4 studied the prevalence of PTSD intru-
sion and avoidance symptomatology in the first 30 days after 
breast cancer diagnosis, with 20% prevalence for intrusion 
symptoms and 19.1% for avoidance symptoms.
For that which regards PTSD assessment strategies 
and PTSD prevalence, Wu et al15 focused on studying the 
overall prevalence estimate of PTSD among breast cancer 
patients and the prevalence estimates related to specific 
PTSD diagnosis tools by means of a meta-analysis. They 
found that the pooled prevalence of PTSD was 9.6% (95% 
CI=7.9%–11.5%). Studies that used the Clinician Admin-
istered PTSD Scale method alone yielded much higher 
prevalence (19%, 95% CI=13.1%–25.5%) than third or fourth 
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edition Structured Clinical Interview for Diagnostic and Sta-
tistical Manual method alone (3.0%, 95% CI=2.2%–3.9%). 
Prevalence estimates for studies that used the methods PTSD 
Checklist-Civilian Version cutoff and Impact of Event Scale 
cutoff were 7.0% (95% CI=3.9%–10.8%) and 15.1% (95% 
CI=12.3%–18.2%), respectively.
Outline of associated sociodemographic 
and comorbidity risk factors
The literature cites different kinds of PTSD-associated 
sociodemographic and comorbidity risk factors but until now 
no consensus is reached about the role they play in association 
to PTSD development as it emerges in Table 3.
Mehnert and Koch9 reported that women diagnosed with 
cancer-related PTSD or acute stress disorder were more likely 
(OR [odds ratio]=22.2) to have a comorbid psychological 
disorder. In particular, a history of anxiety disorders seems 
to be significant in causing PTSD symptoms such as mood 
and  substance use/dependence diagnoses. Furthermore, 
breast cancer patients with PTSD are significantly more likely 
to have a current mood (OR=8.44, 95% CI=2.08–34.35) 
or anxiety disorder other than PTSD (OR=7.33, 95% 
CI=1.37–39.18).10
This evidence is supported by Hegel et al,8 in whose 
sample, prior psychiatric illness and/or treatment was rela-
tively common in PTSD breast cancer patients. PTSD breast 
cancer patients seem to differ from others in criterion A life 
events, F (2, 71)=3.85, p<03, rather than in total number of 
stressful life events.10
The fact of having been physically attacked/abused influ-
ences PTSD prevalence rates10,16 with higher prevalence in 
patients who were abused or physically attacked.
Perez et al5 did not find such a correlation between prior 
trauma and PTSD prevalence although prior traumatic events 
were related to having less social support. Positive cancer 
family and positive cancer relational history are associated 
Table 3 Variables associated to PTSD prevalence in breast cancer patients cited by study
Variables Association to PTSD prevalence No association to PTSD prevalence
Clinical oncology variables
Time since diagnosis Swartzman et al (2017)3, Kangas et al (2002)6 Vin-Raviv et al (2013)11, Hahn et al (2015)16
Type of treatment Swartzman et al (2017)3, Kangas et al (2002)6 Vin-Raviv et al (2013)11, Hahn et al (2015)16
Extent of disease O’Connor et al (2011)12, Shelby et al (2008)10, 
Kangas et al (2002)6
Vin-Raviv et al (2013)11, Hahn et al (2015)16
Type of surgery Shelby et al (2008)10, Kangas et al (2002)6 Vin-Raviv et al (2013)11
Recurrence Kangas et al (2002)6
Positive cancer family history Arnaboldi et al (2014)4
Psychological variables
Comorbid psychological disorders O’Connor et al (2011)12, Mehnert and Koch 
(2007)9, Higgins and Green (2011)7
Prior life stressors Kangas et al (2002)6, Hegel et al (2006)8 Perez et al (2014)5
Elevated psychological distress at diagnosis Hegel et al (2006)8
Emotionally reactive treatment Kangas et al (2002)6, Elklit and Blum et al 
(2011)13
Avoidant coping style Kangas et al (2002)6, Elklit and Blumet al 
(2011)13, Perez et al (2014)5
Hopelessness/helplessness Perez et al (2014)5
Type C personality Perez et al (2014)5
Immature defense style Elklit and Blum et al (2011)13
Negative affectivity Elklit and Blum et al (2011)13
Poor social functioning Kangas et al (2002)6
Reduced physical functioning O’Connor et al (2011)12
Sociodemographic variables
Race/ethnicity Wu et al15, Swartzman et al (2017)3,  
Vin-Raviv et al (2013)11
Hahn et al (2015)16
Age Swartzman et al (2017)3, Vin-Raviv et al (2013)11, 
Perez et al (2014)5, Hahn et al (2015)16
Gender Kangas et al (2002)6 Hahn et al (2015)16
Education Kangas et al (2002)6
Income O’Connor et al (2011)12, Hahn et al (2015)16
Employment status Hahn et al (2015)16
Abbreviation: PTSD, post-traumatic stress disorder.
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with higher levels of PTSD symptoms.4 With the expression 
“positive family history” authors referred to the presence of 
other cancer diagnosis in the family history or in significant 
others.
As regards medical variables, extent of disease and 
type of surgery were demonstrated to be the risk factors 
in developing both PTSD and subsyndromal PTSD,10 but 
there is mixed evidence pertaining to the predictive value of 
medical variables: in some studies, more advanced disease 
stages, recency of treatment at assessment, and experienc-
ing at least one recurrence are associated with more severe 
PTSD symptoms, while in other studies this influence did 
not emerge.11 O’Connor et al12 in their nationwide inception 
cohort of Danish women treated for primary breast cancer 
found that the main predictors of severe post-traumatic stress 
symptoms at 15 months postsurgery were low social status, 
previous physical and mental illness, axillary lymph node 
involvement (>3), and reduced physical functioning at 3 
months postsurgery.
From the review by Swartzman et al,3 it emerges that type 
of treatment influences the prevalence of PTSD diagnosis 
with higher prevalence during chemotherapy. Time since 
diagnosis also influences PTSD prevalence (the more the 
time the lower the prevalence).
It emerges also that geographic provenance of patients 
seems to influence PTSD prevalence with the highest preva-
lence in the Middle East rather than Europe, North America, 
and Asia3. Non-Caucasian breast cancer patients were more 
likely to be diagnosed with PTSD than Caucasians.17
Younger age is also associated with higher prevalence: 
for each additional year increase, PTSD estimates would be 
predicted to decrease by 0.3%.6 The same result concerning 
age was supported by Perez et al5 and Wu et al.15
In the hierarchical multiple regression analysis by Elklit 
and Blum,13 immature defense style, emotional coping, avoid-
ant behavior, and negative affectivity were all implicated as 
predicting variables in PTSD severity 1 year after diagnosis.
Summary of potential links and proposed 
mechanisms by which stress impacts 
cancer risk
Besides the risk of developing PTSD symptoms after the 
diagnosis of cancer, several researchers suggested the pos-
sibility of an inverse correlation, but the reported studies 
conflict in their findings.
PTSD does not turn out as a risk factor for cancer develop-
ment in the cohort study by Gradus et al.18 A total of 4,131 
adults with PTSD and no history of cancer were included, and 
after a 7-year follow-up the evidence showed no significant 
higher incidence of cancer in general, and breast cancer in 
particular. These results seem to exclude a correlation between 
PTSD and breast cancer development, although the study 
did not focus only on breast cancer but included all types of 
cancer. It should be stressed, however, that the results from 
other studies seem more significant, as the researchers tried to 
identify one or more variables as responsible of the interaction 
between psychosocial distress and cancer development.19–21
Stressful life events
The results by Lillberg et al19 put in evidence the role of 
stressful events in the incidence of breast cancer. Among 
10,808 women included in the study, 180 had a breast cancer 
diagnosis within the 15 years of the follow-up. A significant 
correlation was found between stressful life events, such as 
a divorce/separation, the loss of a husband or a close friend, 
and breast cancer incidence.19
But what are the mechanisms by which psychosocial 
distress affects breast cancer development?
Cortisol
Etiologic research has underlined the implications of certain 
hormones in tumorigenesis. The central nervous system 
responses may be affected by psychosocial stress, as well as 
the functions of hypothalamus, pituitary, and adrenal glands. 
Cortisol seems to play an important role especially in breast 
cancer development. During periods of higher stress, the 
cortisol levels are likely to be dysregulated and its presence 
in the organism is prolonged. Laboratory evidence has shown 
how cortisol alters the generation or the activity of estrogen; 
as estrogen appears to be implicated in breast tumorigenesis, 
it is conceivable to identify cortisol as a risk factor.20
Catecholamines, glucorticoids, and other stress hormones 
could vary the tumor microenvironment and they could acti-
vate oncogenic viruses.21
The results of the etiology studies are not easy to interpret, 
because of the type of study design and the method by which 
the exposure to stress has been measured.
Several observational studies support the hypothesis 
that exposure to psychological stress increases the chance 
of developing breast cancer.20
In conclusion, stress-related psychosocial factors seem 
to exert effects especially on the survival rates rather than on 
the incidence of the disease,21 even though an unequivocal 
implication of distress in breast cancer is hard to demonstrate. 
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On this basis, it seems plausible that prolonged or cumulative 
exposure to some psychosocial-stress factors increases the 
risk of breast cancer and lowers the survival rate. In addi-
tion, psychosocial factors may affect cancer development in 
different ways, depending on the type of cancer.
Role of predicting factors for early 
diagnosis/prevention of PTSD in breast 
cancer
A number of factors may be potentially identified as predic-
tors for an early diagnosis of PTSD including individual 
influences on psychological distress including biological 
parameters, personality traits, coping strategies, and social 
support.
At an individual level, it appears that level of distress 
positively correlates with personal history of previous high 
level of hormone serum of T3 and T4.22
As Loo et al22 reported “The majority of people with 
PTSD show a low level of cortisol and high levels of cat-
echolamines in urine through the activation of the hypotha-
lamic–pituitary–adrenal (HPA) axis, which has been a major 
focus of scrutiny in patients with PTSD.”
At clinical level, another important biological pattern was 
the elevated blood pressure and pulse ratio.22 Interesting cor-
relations with neurobiological patterns were also found. The 
review by Rustad et al23 pointed out the association between 
the augmented sympathetic nervous system output with the 
PTSD. Chronic high stress is regulated by precise neurobio-
logical substrates, including the HPA axis and monoamine 
neurotransmitters implicated in the anxiety circuit. Cytokines 
influence the HPA axis and they can induce chronic activation 
of the immune system causing high level of stress through 
PTSD. Apart from physiological values, sociodemographic 
factors resulted not particularly relevant. In our review, age 
group, gender, and history of substance abuse seemed not to 
have any effect on psychological PTSD.18
The importance of age is controversial in the genesis 
of the disorder. While the great majority of the studies 
considered did not report differences in age and stress, the 
research of Perez et al5 stated that younger women experi-
ence more increased distress. However, as the research by 
Andrykowski and Kangas15 mentions, it is always very 
important to highlight the great interindividual variability. 
In particular, the exposure to PTSD has been correlated 
with the phases following diagnosis. As Kangas et al6 stated 
“it is important to recognize the grief reactions that people 
can experience after receiving a cancer diagnosis. Adjusting 
to a poor prognosis requires an adjustment period in which 
one needs to integrate much novel information, including 
reevaluating one’s life goal”.
Regarding personality, the relationship between traits 
and psychological distress was examined in two studies. The 
active individual’s reaction to life events is thought to alleviate 
psychological PTSD directly by contributing to expectations 
of a positive outcome.19
Similarly, the study by Chida et al21 showed that stress-
prone personality or unfavorable coping styles and negative 
emotional responses are correlated with higher stress and 
high mortality. Type C personality seemed also to have a 
mediator effect between breast cancer diagnosis and PTSD.5
Accordingly, Type C personality persons, who are signifi-
cantly not assertive, and not oriented to satisfy their wants, 
needs, or desires, are more exposed to PTSD than others. Type 
C personality can be intended as a psychological disposition 
whereby an individual seems quiet and thoughtful, but is in 
fact frustrated and angry. Difficulties in processing negative 
emotions such as anger are specific of this kind of personal-
ity functioning: a person with a typical type C personality 
appears to lack emotions, does not usually assert themselves 
and strives to pacify others.
Regarding coping strategies, the use of active coping 
skills has consistently been related to lower levels of distress. 
Particularly, the epidemiological study by Lilliberg et al19 with 
10,808 cases of patients showed that the inability to cope 
with stressful events happened in the personal history of the 
patients during the previous 5 years was highly correlated 
with the development of PTSD and breast cancer. Example 
of such traumatic events included divorce or separation, 
death of a husband, and death of a close relative or friend.19
Similarly, Perez et al5 have shown that negative coping 
strategies such as anxious preoccupation (β=1.20) and cogni-
tive avoidance (β=0.91) are important predictors of PTSD. 
The review by Shand et al24 concluded by stating that some 
particular constructs such as optimism, spirituality, and posi-
tive attitude are strongly correlated with the capacity to cope 
and to face adverse events in breast cancer.
Finally, a relationship between social support and psy-
chological PTSD was found in one study. In this research, it 
was found that patients perceiving less social support were 
more at risk of developing stress and PTSD.5
Implications for co-treatment
Being diagnosed with breast cancer and concomitant PTSD 
symptoms or syndrome has influences on different areas of 
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patients’ quality of life (QoL), on the patient’s clinical path-
way, and on the way patients cope with their breast cancer 
experience and show adjustment processes. Patients with 
PTSD had significant lower functional performance status, 
physical health-related QoL, and mental health-related QoL 
scores (p<0.05).10 Again, levels of occupational impairment 
were higher in PTSD patients, and by 18 months postdiag-
nosis they were more likely to having sought psychological 
treatment.10 Hegel et al8 confirmed these evidences: patients 
who screened positive for PTSD were significantly lower on 
the Physical Component Score than patients who screened 
negative (mean score 47.1 vs 54.1, p<0.01) although not in 
the range of clinical significance. The PTSD patients were 
significantly statistically and clinically lower on the SF-8 
Mental for mental health-related QoL than screen-negative 
patients (mean score, 36.9 vs 48.8, p<0.0).
Moreover, it seems that the effects of PTSD are long-
term effects: patients with high levels of PTSD symptoms 
before surgery maintain these levels, showing difficulties 
in adjusting to illness, even 2 years later4 demonstrating an 
impact of PTSD symptomatology on long-term adjustment 
to breast cancer.
A specific clarification is required regarding the effect 
of PTSD on cognitive functioning: Hermelink et al25 dem-
onstrated in a large prospective study that limited cognitive 
impairment that may occur in breast cancer patients already 
before treatment initiation is most probably largely caused by 
traumatic stress symptoms as a consequence of breast cancer 
diagnosis. Thus, PTSD symptoms were demonstrated to con-
tribute much more to perceived cognitive impairment than 
did chemotherapy26 with huge impact on QoL, relationship, 
and communication issues with the multidisciplinary team.
In front of these evidences, the co-treatment of this psy-
chological disturbance is warranted to guarantee patients 
with a proper medical pathway. The implementation of 
 co-treatment can be intended either in the effort of routinely 
assessing patients for the presence of the syndrome6 but also 
developing multidisciplinary policies that focus on health 
care professional education and training as the main goal 
because it is necessary with this kind of frail patients to use 
specific way of delivering information regarding diagnosis, 
treatment, and illness with attention to their traumatized 
state of mind.4
Discussion
PTSD is undoubtedly a complex psychiatric syndrome, and 
the aim of our review was to present a comprehensive paper 
summarizing its prevalence in the breast cancer setting, the 
associated sociodemographic and comorbidity risk factors 
together with the other “edge of the sword,” namely, those 
potential links whereby stress could impact both the cancer 
risk and coping with the cancer experience. Implications for 
co-treatment were also addressed (Figure 2).
We found that PTSD was studied from different perspec-
tives in the literature, in different disease phases and by means 
of different self-reported or qualitative measures.6–17
This methodological heterogeneity leads to a great vari-
ability in study results and, therefore, to difficulties and 
cautiousness in the generalizability of data. Sample sizes 
in the revised studies were also small and the lack of RCTs 
Figure 2 Synthesis of the main results of the systematic review.
Abbreviation: PTSD, post-traumatic stress disorder.
1. PTSD prevalence in breast cancer patients ranges from 0% to 32.3% depending on disease stage, screening
    phase, and assessment instruments
2. There is no consensus among the scientific community regarding associated risk factors: psychosocial factors 
    are more relevant than clinical objectivity in causing the disorder
3. Personality traits and functioning, such as a Type C personality, are risk factors to develop PTSD
4. Ethnicity is relevant in influencing prevalence: Middle East patients are at higher risk of developing the
    syndrome
5. PTSD has a long-lasting effect on cognitive status, adjustment mechanisms, and patients’ quality of life,
    and it can interfere with medical care 
6. Health care system should offer preventive and health care continuity policies by routinely assessing for PTSD
    in newly diagnosed breast cancer patients by means of validated screening instruments. Health care
    professionals should be sustained in developing communication and relationship competences to deal with
    traumatized patients
7. The potential links by which stress can impact cancer risk are today too complex to be demonstrated
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represents an important methodological limitation in the 
published literature.
The prevalence of PTSD in breast cancer patients resulted 
possibly high and was seen to range from 0% to 32.3%3,8–15 with 
different evidence regarding its prevalence over time: some 
studies attest a higher prevalence of PTSD soon after diagnosis 
than at the end of the active treatment phases11 while others 
outline an increase of the prevalence at the end of treatment.10,13
On the other hand, the prevalence of PTSD symptoms 
themselves, without all criteria for a DSM diagnosis being 
fulfilled, is upward of 75% in breast cancer patients,4,10,12,13 and 
it emerges that patients scoring high in avoidant symptoms 
soon after diagnosis will have difficulties in adjustment even 
2 years later. This raises the issue of integrated psychological 
care delivery: usually in Europe, the psychological welfare 
of breast cancer patients in the first year of post-treatment 
is generally not considered a hospital responsibility. Private 
organizations and private mental health care professionals, 
under a National Health Care scheme, deliver psychological 
interventions to patients who survived.13 The fact that PTSD 
symptoms are prevalent also years after the first diagnosis 
alerts health care systems in the direction of offering patients 
health care continuity.
Furthermore, considering the impact of PTSD symptoms 
on patients’ cognitive functioning4,13 and on QoL (mental, 
physical, and emotional),8,10 future research should aim at the 
detection of policies that include PTSD symptoms in breast 
cancer patients’ health care screening, reaching a consensus 
about heterogeneity of measures.17
Are there any variables to be included in screening in 
order to have an idea of how high the risk is that a breast 
cancer patient will develop PTSD? In the literature, no 
agreement has been reached either for clinical variables, or 
for sociodemographic variables. Time since diagnosis, type 
of treatment, and extent of disease are not unanimously 
associated with the development of PTSD demonstrating that 
psychological factors are more relevant than clinical objec-
tivity in causing the disease. Age3,5,11,16 and positive family 
cancer history4 seem to be the only sociodemographic factors 
unanimously associated with a higher risk of developing 
PTSD symptomatology. Among psychological variables, the 
presence of comorbid psychological disorders is responsible 
for a higher risk of developing PTSD8,9,12 so that particular 
attention should be devoted to this category of frail patients 
whose psychiatric history is not routinely recollected.4
At an individual level, a number of immature coping 
mechanisms such as hopelessness/helplessness,5 avoidant 
coping style,5,13 emotionally reactive temperament,13 negative 
affectivity,13 and Type C personality5 are related to the pres-
ence of PTSD symptoms. Biological and chemical aspects, 
related to the HPA axis, are also relevant.22
PTSD is a multifactorial syndrome, and by means of a 
simple blood test its risk could be estimated differently from 
that which occurs in the case of other mental disturbances 
such as depressive symptoms or adjustment disorders whose 
biological correlates are nowadays not so clearly defined. 
Cost-effectiveness evaluation of this preventive screening 
approach is warranted as is typical in chronic conditions.27,28
In a double-edged sword perspective, if we consider 
the role of comorbid factors, previous mental history, and 
stressful life events in developing PTSD, we also argued 
at evaluating the potential links by which stress can impact 
cancer risk but the most relevant evidence from the literature 
is that this link is today too arduous to be demonstrated.18,20 
However, it has been demonstrated in other conditions such 
as pain or chronic blood conditions,28,29 so it may be possible 
that these relations can be shown in future studies.
A novel and not so examined aspect is the transcultural 
approach: ethnicity emerged to be a factor associated with 
PSTD prevalence3,11,17 with the highest prevalence in the 
Middle East rather than Europe, North America, and Asia 
probably due to a socially oriented perception of life stressors 
and to the subjective illness experience, and a qualitative 
research methodology could help in thoroughly comprehend-
ing this aspect.
In conclusion, there is a need for longitudinal, prospective 
studies to identify patients at risk, determine causal or aggra-
vating factors, and develop a preventive intervention policy.
Moreover, future studies should address the issue of stress 
and PTSD in education and training among health operators 
in order to include proper communication and better relation-
ships,30 which may contain the development of that disorder 
and which may lead to better understanding the course of this 
type of problem, as PSTD may occur not immediately after 
diagnosis but also years after first diagnosis.
It should be underlined that the eligible studies of the 
present review accorded with the DSM-IV criteria for PTSD 
diagnosis but not with the newer DSM-V that considers a 
life-threatening disease to be responsible of causing PTSD 
only under some circumstances, that is, when the diagnosis is 
sudden and catastrophic. Given this reason, future research-
ers should be cautious in diagnosing cancer-related PTSD.
Conclusion
Stress is a psychological construct much studied in medicine. 
This is particularly so in the case of chronic disease such as 
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cancer. Cancer of the breast is one of the most studied from 
a psychosomatic perspective because it is one of the most 
prevalent in female population. Despite a number of research 
studies focused on the relationship between stress and breast 
cancer, no unique evidence is available. Undoubtedly, the 
literature demonstrates that a breast cancer diagnosis can be 
responsible for causing stress, particularly in the form of the 
renowned PTSD. Little is known as yet regarding the role that 
previous life stressors and general stress play in determining 
cancer or in influencing the course of the disease.
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